πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 34 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12427201

Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor ant

Sutro Biopharma, Inc. Β· Granted Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12398197

Antibodies with engineered CH2 domains, compositions thereof and methods of using the same

Sutro Biopharma, Inc. Β· Granted Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12351850

Methods of producing full-length antibodies using E. coli

Sutro Biopharma, Inc. Β· Granted Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12269801

Modified amino acids

Sutro Biopharma, Inc. Β· Granted Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12252552

Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates

Sutro Biopharma, Inc. Β· Granted Tue Mar 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12226490

Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and

Sutro Biopharma, Inc. Β· Granted Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12144869

Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and

Sutro Biopharma, Inc. Β· Granted Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12071477

Anti-folate receptor alpha antibody conjugated with hemiasterlins

Sutro Biopharma, Inc. Β· Granted Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11993658

Anti-BCMA antibodies and treatment methods

Sutro Biopharma, Inc. Β· Granted Tue May 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11958909

Antibodies comprising site-specific non-natural amino acid residues, methods of their prep

Sutro Biopharma, Inc. Β· Granted Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11866515

Hemiasterlin derivatives for conjugation and therapy

Sutro Biopharma, Inc. Β· Granted Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11744876

Immunomodulator antibody drug conjugates and uses thereof

Sutro Biopharma, Inc. Β· Granted Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11708413

Anti-CD74 antibody conjugates, compositions comprising anti-CD74 antibody conjugates and m

Sutro Biopharma, Inc. Β· Granted Tue Jul 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11548852

Modified amino acids

Sutro Biopharma, Inc. Β· Granted Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11344626

Antibodies comprising multiple site-specific non-natural amino acid residues, methods of t

Sutro Biopharma, Inc. Β· Granted Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11098131

Anti-EpCAM antibodies, compositions comprising anti-EpCAM antibodies and methods of making

Sutro Biopharma, Inc. Β· Granted Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11098107

Antibodies with engineered CH2 domains, compositions thereof and methods of using the same

Sutro Biopharma, Inc. Β· Granted Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11014983

Anti-Tim-3 antibodies, compositions comprising anti-Tim-3 antibodies and methods of making

Sutro Biopharma, Inc. Β· Granted Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10975150

Anti-CD74 antibodies, compositions comprising anti-CD74 antibodies and methods of using an

Sutro Biopharma, Inc. Β· Granted Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10844090

Hemiasterlin derivatives for conjugation and therapy

Sutro Biopharma, Inc. Β· Granted Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10822414

Anti-PD-1 antibodies, compositions comprising anti-PD-1 antibodies and methods of using an

Sutro Biopharma, Inc. Β· Granted Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10730837

Modified amino acids

Sutro Biopharma, Inc. Β· Granted Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10669347

Antibodies comprising site-specific non-natural amino acid residues, methods of their prep

Sutro Biopharma, Inc. Β· Granted Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10596270

Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor ant

Sutro Biopharma, Inc. Β· Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted